Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (9) 9
humans (8) 8
life sciences & biomedicine (8) 8
oncology (8) 8
female (6) 6
aged (5) 5
cancer (5) 5
care and treatment (5) 5
medicine & public health (5) 5
middle aged (5) 5
adult (4) 4
breast cancer (4) 4
neoplasms - drug therapy (3) 3
treatment outcome (3) 3
anemia - chemically induced (2) 2
anthracyclines (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - adverse effects (2) 2
biological and medical sciences (2) 2
breast neoplasms - drug therapy (2) 2
breast neoplasms - genetics (2) 2
breast neoplasms - pathology (2) 2
cancer patients (2) 2
clinical trials (2) 2
disease-free survival (2) 2
male (2) 2
medical research (2) 2
medical sciences (2) 2
medicine, experimental (2) 2
metastasis (2) 2
neoplasm metastasis (2) 2
neoplasm staging (2) 2
paclitaxel (2) 2
patient outcomes (2) 2
practice (2) 2
receptor, erbb-2 - genetics (2) 2
research (2) 2
risk factors (2) 2
surgery (2) 2
toxicity (2) 2
tumors (2) 2
usage (2) 2
[ sdv.imm ] life sciences [q-bio]/immunology (1) 1
[sdv.imm]life sciences [q-bio]/immunology (1) 1
activities of daily living (1) 1
adverse events (1) 1
aged, 80 and over (1) 1
analysis (1) 1
anemia (1) 1
anemia - drug therapy (1) 1
anemia - physiopathology (1) 1
anemia - therapy (1) 1
anemias. hemoglobinopathies (1) 1
angiogenesis inhibitors (1) 1
anthracyclines - pharmacology (1) 1
antiangiogenic (1) 1
antibiotics, antineoplastic (1) 1
antibiotics, antineoplastic - therapeutic use (1) 1
antineoplastic agents - therapeutic use (1) 1
arizona (1) 1
bacterial typing techniques - methods (1) 1
base sequence (1) 1
bcr-abl tyrosine kinase inhibitors (1) 1
bevacizumab (1) 1
bevacizumab - administration & dosage (1) 1
biomarkers, tumor - genetics (1) 1
biomarkers, tumor - metabolism (1) 1
biomedical research (1) 1
blood transfusion (1) 1
breast neoplasms (1) 1
breast neoplasms - diagnosis (1) 1
breast neoplasms - metabolism (1) 1
breast neoplasms - mortality (1) 1
breast neoplasms - surgery (1) 1
breast oncology (1) 1
capecitabine (1) 1
chemotherapy (1) 1
clinical medicine (1) 1
communication in medicine (1) 1
community health services (1) 1
complications and side effects (1) 1
conceptual frameworks (1) 1
conferences and conventions (1) 1
conferences, meetings and seminars (1) 1
congestive heart failure (1) 1
congresses as topic (1) 1
consensus (1) 1
content validity (1) 1
cyclophosphamide (1) 1
darbepoetin alfa (1) 1
data mining (1) 1
deoxycytidine (1) 1
deoxycytidine - analogs & derivatives (1) 1
deoxycytidine - pharmacology (1) 1
diarrhea (1) 1
disease susceptibility (1) 1
diseases of red blood cells (1) 1
dna primers (1) 1
dna, bacterial - genetics (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Efficacy and Safety of Ixabepilone (BMS-247550) in a Phase II Study of Patients With Advanced Breast Cancer Resistant to an Anthracycline, a Taxane, and Capecitabine
by Edith A. Perez and Guillermo Lerzo and Xavier Pivot and Eva Thomas and Linda Vahdat and Linda Bosserman and Patrice Viens and Can Cai and Brian Mullaney and Ronald Peck and Gabriel N. Hortobagyi
Journal of clinical oncology, ISSN 0732-183X, 08/2007, Volume 25, Issue 23, pp. 3407 - 3414
Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Medical sciences | Tumors | Taxoids - pharmacology | Fluorouracil - analogs & derivatives | Capecitabine | Humans | Middle Aged | Deoxycytidine - pharmacology | Drug Resistance, Neoplasm | Treatment Outcome | Epothilones - therapeutic use | Breast Neoplasms - drug therapy | Disease-Free Survival | Neoplasm Metastasis | Antibiotics, Antineoplastic - therapeutic use | Anthracyclines - pharmacology | Breast Neoplasms - pathology | Adult | Female | Aged | Fluorouracil - pharmacology | Deoxycytidine - analogs & derivatives | Index Medicus | Anthracyclines | Antibiotics, Antineoplastic | Breast Neoplasms | Life Sciences | Immunology | Taxoids | Deoxycytidine | Epothilones | Fluorouracil
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference
by Landercasper, Jeffrey and Attai, Deanna and Atisha, Dunya and Beitsch, Peter and Bosserman, Linda and Boughey, Judy and Carter, Jodi and Edge, Stephen and Feldman, Sheldon and Froman, Joshua and Greenberg, Caprice and Kaufman, Cary and Morrow, Monica and Pockaj, Barbara and Silverstein, Melvin and Solin, Lawrence and Staley, Alicia and Vicini, Frank and Wilke, Lee and Yang, Wei and Cody III, Hiram
Annals of surgical oncology, ISSN 1068-9265, 10/2015, Volume 22, Issue 10, pp. 3174 - 3183
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | Life Sciences & Biomedicine | Science & Technology | Breast Neoplasms - surgery | Reoperation | Congresses as Topic | Humans | Mastectomy, Segmental - standards | Consensus | Societies, Medical | Surgeons | Female | Mammaplasty | Neoplasm Staging | Practice Guidelines as Topic | Radiation Oncology - standards | Lumpectomy | Care and treatment | Cancer patients | Conferences, meetings and seminars | Patient outcomes | Breast cancer | Conferences and conventions | Trade and professional associations | Index Medicus | Breast Oncology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Randomized Comparison of Every-2-Week Darbepoetin Alfa and Weekly Epoetin Alfa for the Treatment of Chemotherapy-Induced Anemia: The 20030125 Study Group Trial
by John Glaspy and Saroj Vadhan-Raj and Ravi Patel and Linda Bosserman and Eddie Hu and Richard E. Lloyd and Ralph V. Boccia and Dianne Tomita and Greg Rossi and 20030125 Study Group Trial
Journal of clinical oncology, ISSN 0732-183X, 05/2006, Volume 24, Issue 15, pp. 2290 - 2297
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Anemias. Hemoglobinopathies | Biological and medical sciences | Medical sciences | Diseases of red blood cells | Tumors | Erythropoietin - administration & dosage | Drug Administration Schedule | Humans | Middle Aged | Anemia - chemically induced | Anemia - therapy | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Recombinant Proteins | Hematinics - administration & dosage | Neoplasms - drug therapy | Erythropoietin - analogs & derivatives | Anemia - drug therapy | Blood Transfusion | Antineoplastic Agents - adverse effects | Female | Aged | Epoetin Alfa | Darbepoetin alfa | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Partnering with a payer to develop a value-based medical home pilot: A west coast practice's experience
by Bosserman, Linda D and Verrilli, Diana and McNatt, Wendy
The American journal of managed care, ISSN 1088-0224, 2012, Volume 18
Journal Article
Details down arrow
5. Full Text Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer
by Hurvitz, Sara A and Bosserman, Linda D and Chan, David and Hagenstad, Christopher T and Kass, Frederick C and Smith, Frederick P and Rodriguez, Gladys I and Childs, Barrett H and Slamon, Dennis J
SpringerPlus, ISSN 2193-1801, 12/2014, Volume 3, Issue 1, pp. 1 - 9
Anthracyclines | Congestive heart failure | Adverse events | Antiangiogenic | Trastuzumab | Science, general | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea
by Rugo, Hope S and Di Palma, Jack A and Tripathy, Debu and Bryce, Richard and Moran, Susan and Olek, Elizabeth and Bosserman, Linda
Breast cancer research and treatment, ISSN 0167-6806, 5/2019, Volume 175, Issue 1, pp. 5 - 15
Diarrhea | Oncology | ErbB receptor | Medicine & Public Health | Tyrosine kinase inhibitor | Cancer | Life Sciences & Biomedicine | Science & Technology | Tyrosine | Antimitotic agents | Strategic planning (Business) | BCR-ABL tyrosine kinase inhibitors | Antineoplastic agents | Drug approval | Risk factors | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Paclitaxel, bevacizumab, and everolimus/placebo as first-line treatment for patients with metastatic HER2-negative breast cancer: a randomized placebo-controlled phase II trial of the Sarah Cannon Research Institute
by Yardley, Denise A and Bosserman, Linda D and O’Shaughnessy, Joyce A and Harwin, William N and Morgan, Susan K and Priego, Victor M and Peacock, Nancy W and Bass, J David and Burris III, Howard A and Hainsworth, John D
Breast cancer research and treatment, ISSN 0167-6806, 11/2015, Volume 154, Issue 1, pp. 89 - 97
Randomized | Medicine & Public Health | HER2-negative | Paclitaxel | Oncology | Metastatic breast cancer | Everolimus | Bevacizumab | Life Sciences & Biomedicine | Science & Technology | Bevacizumab - administration & dosage | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Everolimus - administration & dosage | Breast Neoplasms - drug therapy | Disease-Free Survival | Neoplasm Metastasis | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Adult | Female | Aged | Paclitaxel - administration & dosage | Care and treatment | Oncology, Experimental | Clinical trials | Breast cancer | Product development | Metastasis | Research | Research institutes | Angiogenesis inhibitors | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer
by Yardley, Denise A and Arrowsmith, Edward R and Daniel, Brooke R and Eakle, Janice and Brufsky, Adam and Drosick, David R and Kudrik, Fred and Bosserman, Linda D and Keaton, Mark R and Goble, Sharon A and Bubis, Jeffrey A and Priego, Victor M and Pendergrass, Kelly and Manalo, Yvonne and Bury, Martin and Gravenor, Donald S and Rodriguez, Gladys I and Inhorn, Roger C and Young, Robyn R and Harwin, William N and Silver, Caryn and Hainsworth, John D and Burris III, Howard A
Breast cancer research and treatment, ISSN 0167-6806, 8/2017, Volume 164, Issue 3, pp. 649 - 658
Oncology | Cyclophosphamide | Ixabepilone | Medicine & Public Health | Doxorubicin | Triple-negative breast cancer | Life Sciences & Biomedicine | Science & Technology | Antimitotic agents | Drug resistance in microorganisms | Medical research | Care and treatment | Medicine, Experimental | Breast cancer | Disease susceptibility | Metastasis | Antineoplastic agents | Tubulins | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text The anemia impact measure (AIM): development and content validation of a patient-reported outcome measure of anemia symptoms and symptom impacts in cancer patients receiving chemotherapy
by Leah Kleinman and Katy Benjamin and Hema Viswanathan and Maria Stoeckl Mattera and Linda Bosserman and Douglas W. Blayney and Dennis A. Revicki
Quality of life research, ISSN 0962-9343, 9/2012, Volume 21, Issue 7, pp. 1255 - 1266
Chemotherapy | Anemia | Health care outcome assessment | INSTRUMENT DEVELOPMENT | Fatigue | Oncology | Focus groups | Conceptual frameworks | Symptoms | Quality of life | Lung neoplasms | Instrument development | Qualitative research | Medicine & Public Health | Quality of Life Research | Public Health/Gesundheitswesen | Sociology, general | Content validity | Symptom | Health Care Sciences & Services | Public, Environmental & Occupational Health | Health Policy & Services | Life Sciences & Biomedicine | Science & Technology | Humans | Middle Aged | Psychometrics - instrumentation | Focus Groups | Anemia - chemically induced | Male | Neoplasms - drug therapy | Activities of Daily Living | Anemia - physiopathology | Aged, 80 and over | Quality of Life | Adult | Female | Aged | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Quantitative measurement of HER2 expression in breast cancers: Comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival
by Yardley, Denise A and Kaufman, Peter A and Huang, Weidong and Krekow, Lea and Savin, Michael and Lawler, William E and Zrada, Stephen and Starr, Alexander and Einhorn, Harvey and Schwartzberg, Lee S and Adams, John W and Lie, Yolanda and Paquet, Agnes C and Sperinde, Jeff and Haddad, Mojgan and Anderson, Steve and Brigino, Marlon and Pesano, Rick and Bates, Michael P and Weidler, Jodi and Bosserman, Linda
Breast cancer research : BCR, ISSN 1465-5411, 03/2015, Volume 17, Issue 1, pp. 41 - 41
Prognosis | Follow-Up Studies | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Breast Neoplasms - metabolism | Young Adult | Neoplasm Grading | Biomarkers, Tumor - metabolism | Adult | Female | Retrospective Studies | Reproducibility of Results | Risk Factors | Kaplan-Meier Estimate | Tumor Burden | Immunohistochemistry - methods | Breast Neoplasms - genetics | Breast Neoplasms - mortality | Aged | Biomarkers, Tumor - genetics | Breast Neoplasms - diagnosis | Neoplasm Staging | In Situ Hybridization, Fluorescence - methods | Immunohistochemistry | Medical research | Cancer patients | Care and treatment | Patient outcomes | Fluorescence | Medicine, Experimental | Breast cancer | Formaldehyde | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. The challenge of managing increasingly complex cancer toxicity
by Bosserman, Linda D
Oncology (Williston Park, N.Y.), ISSN 0890-9091, 2014, Volume 28, Issue 6, pp. 454 - 454
Life Sciences & Biomedicine | Oncology | Science & Technology | Antineoplastic Agents - adverse effects | Humans | Medical Oncology - trends | Neoplasms - drug therapy
Journal Article
Details down arrow
12. Implementing EHRs in community oncology practices
by Presant, Cary A and Bosserman, Linda and McNatt, Wendy and Emilio, Brandon
Oncology (Williston Park, N.Y.), ISSN 0890-9091, 2011, Volume 25, Issue 1, pp. 19 - 22
Life Sciences & Biomedicine | Oncology | Science & Technology | Health Services Needs and Demand | Medical Oncology | Humans | Biomedical Research | Data Mining | Community Health Services | Electronic Health Records | Electronic Prescribing | Quality of Health Care
Journal Article
Details down arrow
13. Full Text Molecular Typing of Novel Rickettsia rickettsii Isolates from Arizona
by EREMEEVA, MARINA E and BOSSERMAN, ELIZABETH and ZAMBRANO, MARIA and DEMMA, LINDA and DASCH, GREGORY A
Annals of the New York Academy of Sciences, ISSN 0077-8923, 10/2006, Volume 1078, Issue 1, pp. 573 - 577
Rickettsia rickettsii | VNTR | molecular marker | Molecular marker | DNA, Bacterial - genetics | DNA, Bacterial - isolation & purification | Rickettsia rickettsii - genetics | Rickettsia rickettsii - isolation & purification | Base Sequence | Polymerase Chain Reaction | Molecular Sequence Data | DNA Primers | Bacterial Typing Techniques - methods | Arizona | Minisatellite Repeats | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights